⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1310663 | 0.93 | — | — | |
| SCHEMBL4431068 | 0.93 | — | — | |
| SCHEMBL28334842 | 0.86 | — | — | |
| Bromide SCHEMBL160771 | 0.86 | — | — | |
| Hydrogen Sulfide SCHEMBL15022782 | 0.86 | — | — | |
| Water SCHEMBL11749306 | 0.86 | — | — | |
| SCHEMBL4431070 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL161961 | 0.86 | — | — | |
| Iodide SCHEMBL11793013 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL27863024 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105738300-B | Detect kit, method and the purposes of KAPPA light chain content | 潍坊三维生物工程集团有限公司 | 2019-04-30 | — | — | CN | disclosed |
| CN-107074941-A | Bispecific antibody and for ophthalmologic method | 豪夫迈·罗氏有限公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-105548573-A | Kit and method for detecting content of KAPPA light chain and application | WEIFANG 3V BIOLOGICAL ENG GROUP CO LTD | 2016-05-04 | — | — | CN | disclosed |
| CN-105548574-A | Kit and method for detecting content of C1 inhibitor and application | WEIFANG 3V BIOLOGICAL ENG GROUP CO LTD | 2016-05-04 | — | — | CN | disclosed |
| CN-105548571-A | Kit and method for detecting content of serum amyloid protein A and application | WEIFANG 3V BIOLOGICAL ENG GROUP CO LTD | 2016-05-04 | — | — | CN | disclosed |
| CN-105548572-A | Kit and method for detecting content of immune globulin D and application | WEIFANG 3V BIOLOGICAL ENG GROUP CO LTD | 2016-05-04 | — | — | CN | disclosed |
| CN-105548575-A | Kit and method for detecting content of LAMBDA light chains and application of kit | WEIFANG 3V BIOLOGICAL ENG GROUP CO LTD | 2016-05-04 | — | — | CN | disclosed |
| EP-2538781-A2 | PROCESS FOR THE CO-ENCAPSULATION OF BIOCIDALLY ACTIVE COMPOUNDS IN CLAY MINERALS FUNCTIONALIZED BY NITROGEN COMPOUNDS | Clariant S.A., Brazil (BR) | 2013-01-02 | — | — | EP | disclosed |
| CN-101683310-B | Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents | SYMRISE GMBH AND CO KG | 2012-12-12 | — | — | CN | disclosed |
| WO-2011103969-A2 | PROCESS FOR THE CO-ENCAPSULATION OF BIOCIDALLY ACTIVE COMPOUNDS IN CLAY MINERALS FUNCTIONALIZED BY NITROGEN COMPOUNDS | CLARIANT S. A. BRAZIL (BR) | 2011-09-01 | — | — | WO | disclosed |
| US-7666436-B1 | Pertussis toxin mutants, Bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines | NOVARTIS AG (CH) | 2010-02-23 | — | — | US | disclosed |
| US-7427404-B1 | Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines | NOVARTIS VACCINES AND DIAGNOSTICS S.R.L. (IT) | 2008-09-23 | — | — | US | disclosed |
| CN-1031892-C | Expression of human proapolipoprotein A-I | UCB SA (BE) | 1996-05-29 | — | — | CN | disclosed |
| EP-0396964-A1 | Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines | SCLAVO S.p.A. (IT) | 1990-11-14 | — | — | EP | disclosed |
| CN-88103118-A | Expression of human Pre-defatted protein A-I | — | 1988-12-14 | — | — | CN | disclosed |